The C. elegans DYRK Kinase MBK-2 Marks Oocyte Proteins for Degradation in Response to Meiotic Maturation  by Stitzel, Michael L. et al.
Current Biology 16, 56–62, January 10, 2006 ª2006 Elsevier Ltd All rights reserved DOI 10.1016/j.cub.2005.11.063Report
The C. elegans DYRK Kinase MBK-2
Marks Oocyte Proteins for Degradation
in Response to Meiotic MaturationMichael L. Stitzel,1,2 Jason Pellettieri,1,3
and Geraldine Seydoux1,2,*
1Howard Hughes Medical Institute and
Department of Molecular Biology and Genetics
2Predoctoral Training Program in Human Genetics
Johns Hopkins School of Medicine
725 N. Wolfe St., PCTB 706
Baltimore, Maryland 21205
Summary
The oocyte-to-embryo transition transforms a differ-
entiated germ cell into a totipotent zygote capable of
somatic development. In C. elegans, several oocyte
proteins, including the meiotic katanin subunit MEI-1
and the oocyte maturation protein OMA-1, must be de-
graded during this transition [1]. Degradation of MEI-1
and OMA-1 requires the dual-specificity YAK-1-related
(DYRK) kinase MBK-2 [2–4]. Here, we demonstrate
that MBK-2 directly phosphorylates MEI-1 and OMA-1
in vitro and that this activity is essential for degra-
dation in vivo. Phosphorylation of MEI-1 by MBK-2
reaches maximal levels after the meiotic divisions, im-
mediately preceding MEI-1 degradation. MEI-1 phos-
phorylation and degradation still occur in spe-9
eggs, which undergo meiotic maturation and exit in
the absence of fertilization [5]. In contrast, MEI-1 phos-
phorylation and degradation are blocked in cell-cycle
mutants that arrest during the meiotic divisions, and
are accelerated in wee-1.3(RNAi) oocytes, which
prematurely enter meiotic M phase (A. Golden, per-
sonal communication). AGFP:MBK-2 fusion relocalizes
from the cortex to the cytoplasm during the meiotic
divisions, and this relocalization also depends on cell-
cycle progression. Our findings suggest that regula-
tors of meiotic M phase activate a remodeling pro-
gram, independently of fertilization, to prepare eggs
for embryogenesis.
Results
MBK-2’s Kinase Activity Is Essential In Vivo
To characterize the kinase activity of MBK-2, we first
tested whether recombinant MBK-2 could phosphory-
late a synthetic peptide (DYRKtide) containing the DYRK
target consensus RX1-3S/TP [6, 7]. Wild-type MBK-2,
but not mutant MBK-2 with a mutation in the predicted
ATP binding site (K196R), could phosphorylate DYRKtide
(Figure 1A), consistent with MBK-2 possessing the ki-
nase activity typical of the DYRK family. To determine if
kinase activity is essential in vivo, we tested whether
MBK-2 and MBK-2(K196R), when fused to green fluores-
cent protein (GFP), could complement the deletion allele
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MREB Rm 401, Salt Lake City, Utah 84112.mbk-2(pk1427) [3]. Embryos derived frommbk-2(pk1427)
mothers are not viable (0% viability n = 1063). Wild-type
GFP:MBK-2 restored viability to 80% (n = 569); in con-
trast, GFP:MBK-2(K196R) did not rescue (0% viability,
n = 198). GFP:MBK-2 and GFP:MBK-2(K196R) were ex-
pressed at comparable levels (Figure S1 in the Supple-
mental Data available with this article online) and in sim-
ilar patterns (Figure 1B). The only difference was that
GFP:MBK-2(K196R) localized to the meiotic spindle in
metaphase of meiosis I (Figure 1Bf, arrowhead, 37/66
embryos), whereas GFP:MBK-2 did not (0/43 embryos).
We conclude that kinase activity, although not essential
for most aspects of GFP:MBK-2 localization, is essential
for MBK-2 function in vivo.
MBK-2 Directly Phosphorylates MEI-1 and OMA-1
In Vitro on Sites Required for Degradation In Vivo
Next,wetestedwhetherrecombinantMBK-2couldphos-
phorylate MEI-1, OMA-1, and POS-1, three proteins that
require MBK-2 for degradation in vivo [2–4]. MBP:MBK-2
could phosphorylate MBP:MEI-1 and MBP:OMA-1, but
neither MBP:POS-1 nor MBP alone (Figure 1C). MBK-2
(K196R) did not phosphorylate any target, confirming
that MBK-2 is the active kinase in this assay (Figure S2A).
MEI-1 and OMA-1 contain one and two RX1-3S/TP
consensus sites, respectively, whereas POS-1 does
not contain any (Figure S2B and data not shown). In
MEI-1 and OMA-1, one copy of the consensus overlaps
with a PEST sequence, a motif commonly found in pro-
teins with high turnover [8]. Disruption of these DYRK
sites [MEI-1(S92A) and OMA-1(P240L)] reduced MBK-
2’s ability to phosphorylate each substrate (Figure 1C).
We conclude that MBK-2 can phosphorylate MEI-1 and
OMA-1 on DYRK consensus sites embedded in PEST se-
quences (also see below).
OMA-1(P240L) exhibits increased protein stability
in vivo and causes embryonic lethality [9, 10], suggesting
that phosphorylation by MBK-2 is required for OMA-1
degradation. To test whether phosphorylation by MBK-2
is also required for MEI-1 degradation, we examined
the distribution of MEI-1(S92A) fused to GFP. To avoid
the lethality associated with failure to degrade MEI-1,
we introduced a second mutation, R36C, to knock out
MEI-1 catalytic activity [11, 12]. Like wild-type MEI-1,
GFP:MEI-1(R36C) was rapidly degraded during the tran-
sition from meiosis to mitosis (Figure 1D). In contrast,
GFP:MEI-1(R36C,S92A) was maintained past the first
mitotic division (Figure 1D). We conclude that MBK-2
consensus sites in MEI-1and OMA-1 are required for
timely degradation in vivo.
Phosphorylation of MEI-1 by MBK-2 Precedes
Degradation In Vivo
To investigate the dynamics of MEI-1 phosphorylation
in vivo, we generated an antibody specific for MEI-1
phosphorylated on S92 (P-MEI-1; see Experimental Pro-
cedures). Antibody specificity was confirmed with west-
ern blots of in vitro-phosphorylated proteins (Figure 2A)
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57Figure 1. In Vitro and In Vivo Properties of
Wild-Type and Kinase-Inactive (K196R)
MBK-2
(A) In vitro phosphorylation of DYRKtide by
MBK-2. Serial 3-fold dilutions of MBP:MBK-
2 fusions were incubated with 1 mM DYRKtide
in the presence of g-32P-ATP (top). Equal
loading of DYRKtide was confirmed by silver
(Ag) stain (middle). MBP:MBK-2 amounts in
each reaction were confirmed by a-MBP
western blot (bottom).
(B) In vivo localization of GFP:MBK-2 and
GFP:MBK-2(K196R) in mbk-2(pk1427) mu-
tants. Live embryos expressing wild-type
(Ba–e) or kinase-inactive (K196R) (Bf–j)
GFP:MBK-2. Both fusions are found on the
periphery (cortex) of oocytes (Ba and Bf), co-
alesce into cortical puncta of unknown iden-
tity by anaphase I (Bb and Bg), internalize,
and dissipate into the cytoplasm as meiosis
progresses and is completed (Bc–d and Bh–i).
At mitosis, each fusion is predominantly cyto-
plasmic and accumulates on the mitotic spin-
dle and chromatin (Be and Bj). The arrowhead
in Bf points to GFP:MBK-2(K196R) on the
meiotic spindle; arrows show examples of
GFP:MBK-2 on centrosomes. Embryos are
oriented with anterior to the left and posterior
to the right.
(C) MBK-2 phosphorylates MEI-1 and OMA-1 directly in vitro. MBP:MBK-2 was incubated with the indicated MBP fusions in kinase buffer with
g-32P-ATP, run on a NuPAGE 4%–12% Bis-Tris gel (Invitrogen), and stained with Simply Blue SafeStain (lower panel, Invitrogen). A Phosphoim-
ager was used to detect 32P incorporation (upper panel). The faint band present in the MBP, POS-1, and MEI-1(S92A) lanes is autophosphory-
lated MBP:MBK-2. MW denotes molecular weight.
(D) S92 is required for MEI-1 degradation in vivo. Fluorescence of live embryos in the uterus of hermaphrodites expressing GFP:MEI-1
(R36C) (top) or GFP:MEI-1(R36C, S92A) (bottom) is shown. Dotted lines outline embryos that are arranged, youngest to oldest, from left to right.
The arrowhead in the top panel marks an example of GFP:MEI-1 in a polar body. Numbers indicate the number of gonad arms exhibiting the
expression patterns shown/total number of gonadal arms examined. Fluorescence below the embryos is due to autofluorescence of the her-
maphrodite gut.and by comparing immunostained wild-type embryos
and mutant embryos lacking MEI-1 or MBK-2 (Table S1).
P-MEI-1 was first detected on the maternal chromatin
in anaphase of meiosis I (Figure 2Bg, open arrowhead,
and Table S2). P-MEI-1 in the cytoplasm was first de-
tected during meiosis II and reached peak levels during
pronuclear formation (meiotic exit; Figure 2Bh–i). P-MEI-1
levels dropped sharply between pronuclear formation
and the first cell division (Figure 2Bi–j), except in the polar
bodies (filled arrowhead, Figure 2Bh–j). Comparison of
the relative cytoplasmic intensities of GFP:MEI-1 and
P-MEI-1 revealed that (1) the sharp increase in P-MEI-1
levels precedes the decline of GFP:MEI-1 and (2) the dis-
appearance of P-MEI-1 coincides with disappearance of
GFP:MEI-1 (Figure 2C). Consistent with loss of P-MEI-1
being due to degradation, P-MEI-1 levels remained
steady in mel-26(RNAi) embryos, which do not degrade
MEI-1 (data not shown). We conclude that phosphoryla-
tion of MEI-1 by MBK-2 closely precedes MEI-1 degra-
dation in vivo.
Cell-Cycle Dependence of MEI-1 Phosphorylation
and MEI-1 and OMA-1 Degradation
In the absence of sperm, C. elegans oocytes arrest in
prophase of meiosis I [13]. The sperm-derived MSP pep-
tide activates oocyte maturation, ovulation, and the first
meiotic division in the oocyte closest to the sperma-
theca [14]. Fertilization triggers the second meiotic divi-
sion and the switch to mitosis [5]. To determine which ofthese events is required to activate MEI-1 and OMA-1
degradation, we examined mutants defective in fertiliza-
tion or meiotic progression. We describe results here for
GFP:MEI-1, but have also obtained similar data for
OMA-1:GFP (data not shown).
spe-9(hc52) hermaphrodites contain sperm that stim-
ulate oocyte maturation but do not fertilize oocytes [15,
16]. Oocytes are ovulated and reach anaphase of the first
meiotic division, but eventually exit the meiotic cell cycle
without extruding a polar body or forming a meiosis II
spindle [5]. We found that GFP:MEI-1 was degraded
shortly after ovulation in spe-9(hc52) hermaphrodites
(Figure 3B). This degradation was dependent on MBK-2,
because it was blocked when MBK-2 was depleted
by RNAi (Figure 3C). Furthermore, we detected robust
P-MEI-1 in ovulated spe-9(hc52) eggs with decondens-
ing chromatin (Figure 3K). We conclude that fertilization
and the second meiotic division are not required for
MEI-1 phosphorylation or degradation.
Hermaphrodites that lack the cell-cycle regulators
CDK-1 (cyclin-dependent kinase) and MAT-1 (anaphase-
promoting complex/cyclosome [APC/C] subunit) ovu-
late and fertilize oocytes that arrest in prophase of meio-
sis I (cdk-1) or in metaphase of meiosis I (mat-1) [17–19].
In both cases, we found that GFP:MEI-1 was not de-
graded in the arrested embryos (Figures 3D and E). In
addition, we did not detect P-MEI-1 in mat-1(RNAi) em-
bryos (Figure 3L). We conclude that arrest before ana-
phase I is sufficient to block MEI-1 phosphorylation
and degradation even in the presence of fertilization.
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58Figure 2. MEI-1 Is Phosphorylated by MBK-2 at S92 In Vivo Prior to Its Degradation
(A) a-P-MEI-1 antibody specifically recognizes S92-phosphorylated MEI-1 in vitro. The indicated MBP fusion proteins were incubated in kinase
buffer with unlabeled ATP or g-32P ATP. Reaction products were separated as in Figure 1C, and phosphorylated MEI-1 was detected with a-P-
MEI-1 (1:2000 dilution; Experimental Procedures) after transfer to a nitrocellulose membrane (top) or 32P incorporation was measured as in Fig-
ure 1C (g-32P ATP, middle). Equal loading for the western was confirmed by amido-black staining of the membrane (bottom). MW denotes mo-
lecular weight, expressed in kD.
(B) Dynamics of MEI-1 phosphorylation in vivo. Fixed embryos at the indicated stages expressing GFP:MEI-1 (Ba–e) or stained with a-phospho-
MEI-1 antibody (Bf–j) are shown. P-MEI-1 is first detected on the chromatin at anaphase of Meiosis I (Bg, open arrowhead; see also Table S2). P-
MEI-1 staining was also detected in polar bodies (Bh–j, arrowheads). PN denotes pronuclear.
(C) Graph of GFP:MEI-1 and P-MEI-1 levels in wild-type and cul-2(RNAi) embryos from metaphase of meiosis I through the 2-cell stage. Two
vertical red lines on the x axis represent the point in meiosis where cul-2(RNAi) mutants temporarily arrest. Values plotted are the mean value
6 standard error (see Experimental Procedures). PN denotes pronuclear.Depletion of the cullin CUL-2 and the leucine-rich re-
peat protein ZYG-11 by RNAi delays metaphase of mei-
osis II for 30–40 min before zygotes eventually exit mei-
osis and switch to mitosis [20, 21]. Consistent with this
temporary arrest, we found that GFP:MEI-1 degradation
was delayed in cul-2(RNAi) embryos (Figure 3F) and
zyg-11(RNAi) embryos (62/68 gonadal arms examined,
data not shown). P-MEI-1 levels in metaphase II-arrested
cul-2(RNAi) embryos were low and comparable to those
measured in wild-type embryos at the same stage (Fig-
ure 2C). Furthermore, cul-2 embryos that progressed
past the meiosis II arrest reached only one-third the level
of P-MEI-1 compared to wild-type embryos (Figure 2C).
These results suggest that timely progression through
meiosis is required to induce a burst of MEI-1 phosphor-
ylation.
To test whether meiotic progression is sufficient to
stimulate MEI-1 degradation, we examined hermaphro-
dites depleted for the negative regulator WEE-1.3. WEE-
1.3 is the C. elegans Myt1 kinase, which inhibits CDK-1
activity by phosphorylation [22]. wee-1.3(RNAi) causes
oocytes in the proximal gonad to prematurely enter mei-
otic M phase (A. Golden, personal communication). Wefound that GFP:MEI-1 was degraded prematurely in the
gonad of wee-1.3(RNAi) hermaphrodites (Figure 3G).
Furthermore, we detected P-MEI-1 in unovulated oo-
cytes in 9/13 wee-1.3(RNAi) gonads (Figure 3M) com-
pared to 0/19 wild-type gonads (data not shown). Pre-
mature degradation of GFP:MEI-1 in wee-1.3(RNAi) was
dependent on MBK-2 and meiotic progression, because
it could be blocked by also depleting MBK-2, CDK-1, or
MAT-1 (Figures 3H–3J). Taken together, these data sug-
gest that precocious meiotic progression is sufficient to
activate MEI-1 phosphorylation and degradation.
Cell-Cycle Dependence of GFP:MBK-2 Dynamics
GFP:MBK-2 relocalizes abruptly from the cortex to corti-
cal puncta in anaphase/telophase of meiosis I [3, 5] and
progressively from cortical puncta to the cytoplasm dur-
ing meiosis II and meiotic exit (Figure 1Ba–d). Consistent
with two distinct steps of relocalization, embryos ar-
rested before or during metaphase I maintain GFP:MBK-2
uniformly at the cortex (Figures 4B and 4C and [3]),
whereas embryos arrested in metaphase II maintain
GFP:MBK-2 in cortical puncta, with some puncta in the
cytoplasm (Figure 4D and 20/24 zyg-11(RNAi) gonads,
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59Figure 3. Meiotic Maturation, Not Fertiliza-
tion, Is Required for MEI-1 Phosphorylation
and Degradation
(A–J) Fluorescence photomicrographs of oo-
cytes and embryos expressing GFP:MEI-1 in
hermaphrodites with the indicated geno-
types. The spermatheca is indicated by an
asterisk; oocytes are to the left, embryos to
the right. Both are arranged, youngest to old-
est, from left to right. Numbers refer to the
number of gonadal arms with phenotype
shown/total number of gonadal arms exam-
ined. Exceptional arms were consistent with
incomplete penetrance of the RNAi treat-
ment.
(K–M) Fixed embryos or oocytes of the indi-
cated genotype stained with a-phospho-
MEI-1. The localized high concentration of
P-MEI-1 in spe-9(hc52) (arrowhead in [K]) cor-
responds to the maternal chromatin as de-
tected by DAPI (not shown). Numbers in (K)
and (L) indicate the number of eggs with the
phenotype shown/total number examined.
Numbers in (M) refer to the number of go-
nadal arms with at least one P-MEI-1-positive
oocyte/total number of gonadal arms exam-
ined.data not shown). In spe-9 eggs, GFP:MBK-2 progressed
from the cortex into cortical puncta and the cytoplasm
as in wild-type embryos, suggesting that meiotic exit,
rather than meiosis II, is critical (Figure 4E and [5]). In
wee-1.3(RNAi) oocytes, relocalization of GFP:MBK-2 to
cortical puncta and to the cytoplasm occurred preco-
ciously in oocytes (Figure 4F and A. Golden, personal
communication). This premature relocalization was
blocked by CDK-1 and MAT-1 depletion (Figures 4G
and 4H). We conclude that GFP:MBK-2 relocalizes
from the cortex to the cytoplasm in a two-step process
linked to progression past metaphase I and possibly to
meiotic exit.
Discussion
Phosphorylation by MBK-2 Marks Oocyte Proteins
for Degradation
Several observations support the hypothesis that phos-
phorylation by MBK-2 triggers MEI-1 degradation at mei-otic exit. First, MBK-2 phosphorylates MEI-1 on S92 di-
rectly in vitro. Second, S92 is phosphorylated in vivo,
and this phosphorylation requires MBK-2. Third, S92
phosphorylation immediately precedes MEI-1 degrada-
tion. Finally, substitution of S92 with the nonphosphory-
latable amino acid alanine blocks MEI-1 degradation.
How does phosphorylation stimulate MEI-1 destruc-
tion? Degradation of MEI-1 depends on recognition by
MEL-26, the substrate recruitment factor for the E3
ubiquitin ligase MEL-26/CUL-3 [1]. The expression pat-
tern of MEL-26 is not yet known, but one possibility is
that phosphorylation by MBK-2 increases the affinity
of MEI-1 for MEL-26 or the MEL-26/CUL-3 complex at
meiotic exit. For example, phosphorylation of Sic1p by
cyclin/Cdk stimulates its recognition by Cdc4p during
the G1/S transition in S. cerevisiae [23]. Whether MEI-1
needs to be phosphorylated to interact with MEL-26
in vivo remains to be determined.
MBK-2 also phosphorylates OMA-1 in vitro on a site
essential for degradation in vivo, suggesting that OMA-1Figure 4. Meiotic Maturation, Not Fertiliza-
tion, Is Required for GFP:MBK-2 Redistribu-
tion
(A–H) Fluorescence photomicrographs of oo-
cytes and embryos expressing GFP:MBK-2
in hermaphrodites with the indicated geno-
types. Oocytes and embryos are arranged
as described in Figure 3. Arrows point to oo-
cytes or embryos with MBK-2 puncta. An en-
larged surface view of the oocyte marked by
an arrow in (F) is shown in the inset. Numbers
refer to the number of gonadal arms with phe-
notype shown/total number of gonadal arms
examined. Exceptional arms were consistent
with incomplete penetrance of the RNAi
treatment or incomplete penetrance of the
temperature-sensitive allele mat-1(ax227).
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ayama et al. (this issue of Current Biology [25]) indepen-
dently have obtained similar results. Additionally, Nishi
and Lin have demonstrated that OMA-1 phosphorylation
occurs in vivo and peaks at meiotic exit [24], just as we
report here for MEI-1. Unlike MEI-1, however, OMA-1 is
not degraded until after the first mitosis. Consistent
with this delay, OMA-1 degradation also requires phos-
phorylation by a second kinase [24].
The human DYRK kinase DYRK1B/Mirk has also been
reported to destabilize target proteins. During differenti-
ation of C2C12 myoblasts, DYRK1B/Mirk phosphory-
lates cyclin D1, leading to its destruction and G0/G1 cell-
cycle arrest [26]. Other DYRK1B/Mirk targets, however,
have been reported to become stabilized or to change
localization following phosphorylation [27–29]. Together
with our findings, these studies suggest that a common
role for DYRK kinases may be to facilitate developmen-
tal transitions by modifying the stability and/or localiza-
tion of multiple target proteins in differentiating cells.
Activators of Meiotic M Phase Stimulate
Oocyte-Protein Degradation
Transition from an oocyte to an embryo requires comple-
tion of the meiotic divisions and fertilization. In most ani-
mals, oocytes are released from prophase arrest by mat-
uration and progress until a second arrest point (typically
metaphase I or II), pending fertilization [30]. Calcium sig-
naling at fertilization releases oocytes from this second
arrest, allowing completion of the meiotic divisions and
meiotic exit [31]. In this respect, C. elegans differs from
most commonly studied model systems because fertil-
ization is not required for meiotic exit [5]. Unfertilized,
matured oocytes arrest temporarily in anaphase I, but
eventually exit meiosis without forming a second meiotic
spindle [5]. This unusual property allowed us to deter-
mine whether meiosis or fertilization is most directly re-
quired for MBK-2-dependent events. We found that mei-
otic maturation, rather than fertilization, is necessary and
sufficient to induce MEI-1 phosphorylation and degrada-
tion. At this point, we do not know whether MEI-1 phos-
phorylation is activated as a secondary consequence of
meiotic maturation or depends more directly on a spe-
cific cell-cycle activator of meiotic M phase. MEI-1 phos-
phorylation is first detected on the meiotic spindle in ana-
phase of meiosis I, with peak levels reached by meiotic
exit. OMA-1 phosphorylation also first peaks at meiotic
exit [24], suggesting that this timing is specified by
a property intrinsic to MBK-2 rather than its substrates.
How is MBK-2 activated during meiotic progression?
A GFP:MBK-2 fusion relocalizes from the cortex, to cor-
tical puncta, and to the cytoplasm during the meiotic di-
vision. Because MEI-1 and OMA-1 are both cytoplasmic
proteins, an attractive possibility is that release of MBK-2
from the cortex allows it to reach its targets. Examination
of the localization dynamics of endogenous MBK-2 will
be necessary before this hypothesis can be explored
further. Nevertheless, the finding that GFP:MBK-2 reloc-
alizes in a cell-cycle-dependent manner supports the
view that meiotic progression elicits significant changes
throughout the egg. We suggest that the meiotic cell-
cycle machinery activates an egg-wide remodeling pro-
gram that facilitates the transition from a differentiated
germ cell to a totipotent zygote.Experimental Procedures
Nematode Strains, Lethality Analysis, and Temperature-Shift
Experiments
C. elegans strains (Table S3) were derived from the wild-type Bristol
strain N2 and reared with standard procedures [32]. mat-1(ax227)
and spe-9(hc52) hermaphrodites were maintained at 16ºC and
shifted to 25ºC as L4 larvae and as embryos, respectively.
RNAi-Mediated Interference
RNAi-mediated interference (RNAi) was performed with the feeding
method [33], as described in [3, 34]. cdk-1, mat-1, wee-1.3, and mel-
26 RNAi clones were obtained from the Ahringer RNAi library [35],
cul-2 from [36], and mbk-2 from [3].
Cloning and Transgenics
Gateway cloning (Invitrogen) was used to generate all constructs
[37]. Coding sequences were PCR amplified from cDNA and cloned
into pDONR201. pDONR constructs were recombined into pID3.01B
(for N-terminal GFP fusion proteins), pCD1.01 (for RNAi feeding ex-
periments), or pJP1.09 (for N-terminal maltose binding protein fu-
sions). Point mutations in the MEI-1 and OMA-1 coding sequences
were introduced in the pDONR constructs with the QuikChange
Site-Directed Mutagenesis Kit (Stratagene). GFP lines were gener-
ated by the microparticle bombardment method [38].
Expression and Partial Purification of MBP Fusion Proteins
MBP fusions were grown in E. coli strain CAG456 and induced with
300 mM isopropyl-b-D-1-thiogalactopyranoside (IPTG) overnight at
15ºC. Bacterial pellets were washed and resuspended in 10 ml ice-
cold column buffer (20 mM Tris-HCl, 500 mM NaCl, 1 mM EDTA, 1 mM
1,4-Dithio-DL-threitol [DTT], 10% glycerol), passed once through
a French Press, and centrifuged (SW41 rotor at 36,000 RPM, SA300
rotor at 20,000 RPM, or equivalent, for 30 min).
MBP fusions were partially purified from cleared lysates by affinity
chromatography (amylose resin, New England Biolabs) and eluted
with 250 ml column buffer plus 10 mM maltose. Eluates were stored
at 280ºC. Kinase assays were performed as in [39].
Immunoblotting
One hundred and twenty-five hermaphrodites for each genotype in
Figure S1 were collected into 7.5 ml distilled water and frozen in
a dry-ice/ethanol bath. Two and a half microliters of 43 NuPAGE
LDS sample buffer and 0.5 ml 1M DTT were added to each tube,
and the samples were boiled at 100ºC for 5 min before loading. The
proteins were separated on a 4%–12% NuPAGE gel (Invitrogen)
and transferred to a nitrocellulose (Schleicher & Schuell) membrane
[40]. The membrane was blocked in 13 PBS, 0.1% Tween-20
(PBSTw) containing 10% (w/v) nonfat dry milk (NFDM, BioRad) for
1 hr at room temperature and incubated with a-GFP antibody (JL-8
1:1000 dilution, BD Biosciences) in PBSTw plus 5% (w/v) NFDM over-
night at 4ºC. The membrane was washed in PBSTw 3 3 10 min and
incubated with HRP-conjugated secondary (sheep a-mouse [Amer-
sham, NA931V], 1:10,000 dilution) in PBSTw at room temperature for
1 hr, followed by three 10 min washes in PBSTw and ECL detection.
Western blotting to detect MBP:MBK-2 in Figure 1A was performed
as above with a-MBP antibody (#E8032S 1:10,000 dilution, NEB).
Generation of Phosphospecific MEI-1 Antibody, Western
Blotting, and Immunostaining
Rabbit polyclonal antibody 129091/P3 was raised against peptide
CAMTRQSGS(PO3)PEPPA and affinity purified (Bethyl Laborato-
ries). For the western blot in Figure 2A, procedures were performed
as in Immunoblotting, above, with the following antibodies and dilu-
tions: 129091/P3 (1:2000), HRP-conjugated donkey anti-rabbit IgG
(Jackson #711-035-152) (1:10,000). For immunostaining, embryos
were fixed as described in [41] and incubated with 129091/P3
(1:2000 dilution) overnight at room temperature, followed by Alexa
568-conjugated goat anti-rabbit secondary antibody (1:250 dilution,
Molecular Probes).
Microscopic Imaging and Quantitation
Images were acquired with a Hamamatsu ORCA-ER digital camera
attached to a Zeiss Axioplan 2 equipped with Ludl shutters and
MBK-2 and Maternal Protein Degradation
61a mercury lamp. Pictures were acquired and processed with IPLab
software (Scanalytics) and merged and cropped in Photoshop CS.
Images used for the graph in Figure 2C were collected with 0.125 s
exposure, and in all cases, the raw pixel values were within the range
of the CCD camera (0–4095). Using IPLab, we measured the average
pixel intensity for a 703 70 pixel region within each embryo and cor-
rected it for background staining by subtracting the average value
obtained from 4-cell or older embryos on the same slide. Background-
corrected values from three or more same-stage embryos (except
cul-2(RNAi), Metaphase I where n = 1) were averaged and scaled
such that the lowest average value (e.g., Metaphase I for P-MEI-1
staining) equals 0 and the maximal value (e.g., Pronuclear Forma-
tion for P-MEI-1 staining) equals 1. Embryos were staged by DAPI
staining.
Supplemental Data
Supplemental Data include two figures and three tables and are
available with this article online at: http://www.current-biology.
com/cgi/content/full/16/1/56/DC1/.
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Note Added in Proof
Reference 24, which had previously been in press, has been up-
dated to include full publication information for the article.
